Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Howard

Showing results (231-240 of 429) with videos related to

Pageof 43
Sort By:
Clinical Immunology (Orlando, Fla.)|August 27, 2021
Cellular changes in eculizumab early responders with generalized myasthenia gravisYingkai Li, John S Yi, James F Howard, et al.
Muscle & Nerve|January 8, 2026
Risk of Infection Following Clearance of Immunoglobulin G by Plasma Exchange in Myasthenia GravisEric B Creed, Amanda Cyntia Lima Fonseca Rodrigues, Shiyu Wan, et al.
European Journal of Pharmacology|January 5, 2000
Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblastsM Tamura, Y J Chen, E F Howard, et al.
British Journal of Clinical Pharmacology|August 22, 2009
Prospective observational study of adverse drug reactions to diclofenac in childrenJoseph F Standing, Kuan Ooi, Simon Keady, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 5, 2020
Fecal metagenomics and metabolomics reveal gut microbial changes after bariatric surgeryDanxia Yu, Xiao-Ou Shu, Eric F Howard, et al.
Muscle & Nerve|December 24, 2016
QMG and MG-ADL correlations: Study of eculizumab treatment of myasthenia gravisJames F Howard, Miriam Freimer, Fanny O'Brien, et al.
Orphanet Journal of Rare Diseases|March 23, 2023
Sources of variation in estimates of Duchenne and Becker muscular dystrophy prevalence in the United StatesNedra Whitehead, Stephen W Erickson, Bo Cai, et al.
Frontiers in Neurology|December 17, 2020
Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension StudyRichard J Nowak, Srikanth Muppidi, Said R Beydoun, et al.
Neurology|May 11, 1992
CD4+ T-epitope repertoire on the human acetylcholine receptor alpha subunit in severe myasthenia gravis: a study with synthetic peptidesA A Manfredi, M P Protti, X D Wu, et al.
Military Medicine|July 1, 1990
Creating an endoscopy capability in Army community hospitalsR Sheridan, H Servis, J Burkhead, et al.
Pageof 43

Showing results (231-240 of 429) with videos related to

Sort By:
Pageof 43
Clinical Immunology (Orlando, Fla.)|August 27, 2021
Cellular changes in eculizumab early responders with generalized myasthenia gravisYingkai Li, John S Yi, James F Howard, et al.
Muscle & Nerve|January 8, 2026
Risk of Infection Following Clearance of Immunoglobulin G by Plasma Exchange in Myasthenia GravisEric B Creed, Amanda Cyntia Lima Fonseca Rodrigues, Shiyu Wan, et al.
European Journal of Pharmacology|January 5, 2000
Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblastsM Tamura, Y J Chen, E F Howard, et al.
British Journal of Clinical Pharmacology|August 22, 2009
Prospective observational study of adverse drug reactions to diclofenac in childrenJoseph F Standing, Kuan Ooi, Simon Keady, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 5, 2020
Fecal metagenomics and metabolomics reveal gut microbial changes after bariatric surgeryDanxia Yu, Xiao-Ou Shu, Eric F Howard, et al.
Muscle & Nerve|December 24, 2016
QMG and MG-ADL correlations: Study of eculizumab treatment of myasthenia gravisJames F Howard, Miriam Freimer, Fanny O'Brien, et al.
Orphanet Journal of Rare Diseases|March 23, 2023
Sources of variation in estimates of Duchenne and Becker muscular dystrophy prevalence in the United StatesNedra Whitehead, Stephen W Erickson, Bo Cai, et al.
Frontiers in Neurology|December 17, 2020
Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension StudyRichard J Nowak, Srikanth Muppidi, Said R Beydoun, et al.
Neurology|May 11, 1992
CD4+ T-epitope repertoire on the human acetylcholine receptor alpha subunit in severe myasthenia gravis: a study with synthetic peptidesA A Manfredi, M P Protti, X D Wu, et al.
Military Medicine|July 1, 1990
Creating an endoscopy capability in Army community hospitalsR Sheridan, H Servis, J Burkhead, et al.
Pageof 43